Clinical Trial Update: Effect of Rifampicin on the Pharmacokinetics of Apatinib [Phase 1]

View source ↗

Summary

Phase 1 study assessing the effect of Rifampicin on the pharmacokinetics of Apatinib in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Apatinib (apatinib)
• Rifampicin

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED